Form 8-K - Current report:
SEC Accession No. 0001104659-25-051614
Filing Date
2025-05-21
Accepted
2025-05-21 16:15:25
Documents
12
Period of Report
2025-05-19
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2515643d1_8k.htm   iXBRL 8-K 32007
  Complete submission text file 0001104659-25-051614.txt   196917

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA inva-20250519.xsd EX-101.SCH 3002
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE inva-20250519_lab.xml EX-101.LAB 34239
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE inva-20250519_pre.xml EX-101.PRE 22350
14 EXTRACTED XBRL INSTANCE DOCUMENT tm2515643d1_8k_htm.xml XML 3682
Mailing Address 1350 OLD BAYSHORE HIGHWAY SUITE 400 BURLINGAME CA 94010
Business Address 1350 OLD BAYSHORE HIGHWAY SUITE 400 BURLINGAME CA 94010 6502389600
Innoviva, Inc. (Filer) CIK: 0001080014 (see all company filings)

EIN.: 943265960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-30319 | Film No.: 25973333
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)